Go to Content

AMI Inc.

AMI Inc. logo

As of January 2024

City Year of Establishment Founder
Kumamoto 2015 Shimpei Ogawa
Partner VC Latest round of Fundraising Valuation
Real Tech Holdings Co.,Ltd. Series B JPY 4,070 million

  • Contact Information : dev_secretary@ami.inc
  • Website : a new window will openAMI Inc.

Program name

Deep-Tech Startups Support Program

Research theme

Social Implementation of the Heart Sound AI Diagnostic Assistance System and Development of Heart Sound Biomarkers

Business Plan

The main focus is on developing a compact, low-noise, and high signal-to-noise ratio super stethoscope, capable of measuring heart sounds and electrocardiograms. By utilizing signal processing and deep learning technologies, we aim to develop and implement heart failure and heart valve disease estimating AI. Through the commercialization of heart sound analysis Doctor to Doctor service, we aim to screen these cardiac diseases and connect individuals to appropriate treatment in preparation for the upcoming heart failure pandemic.

Research Outline

In this research and development, we will enhance the accuracy of the severity classification AI for heart valve diseases, conduct clinical performance trials, and apply for regulatory approval. Additionally, we will develop two new AIs capable of identifying cardiac conditions, and expand the suite of diagnostic assistance functions. Furthermore, we will have end users utilize the remote auscultation heart sound analysis Doctor to Doctor service and conduct surveys to gather feedback. Using this feedback, we will make interface improvements and assess business viability, and aim for an official release.

Phase Business Area/Field Research Period Research Grant Amount
PCA Healthcare 2023~2024 FY JPY 183 million

International collaborative technology demonstration

Countries/Regions Collaborative activity outline
North America, Asia
  • - Contract with local partners
  • - Relationship development with potential local partner
In this research, the following actions will be taken targeting North America and Asia:
  • - Market research and business plan formulation for phonocardiogram devices in North America and Asia.
  • - Selection of local partners and manufacturers for research and development purposes in North America and Asia, as well as design and development of phonocardiogram devices.
  • - Conducting rule-making surveys for phonocardiogram devices and examining testing methods, as well as preparing for FDA submissions (510(k), pre-sub).

Last Updated : April 30, 2024